Committee Leaves The Door Open For Lundbeck’s Schizophrenia Drug Serdolect
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory panel was clear that there is a cardiovascular risk, but suggested there may be a way to define a subpopulation that can benefit.